These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1620543

  • 1. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
    Apel TW, Mautner J, Polack A, Bornkamm GW, Eick D.
    Oncogene; 1992 Jul; 7(7):1267-71. PubMed ID: 1620543
    [Abstract] [Full Text] [Related]

  • 2. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ, Kohlhuber F, Mautner J, Polack A, Eick D.
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [Abstract] [Full Text] [Related]

  • 3. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A, Strobl L, Feederle R, Schweizer M, Koch E, Eick D, Wiegand H, Bornkamm GW.
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [Abstract] [Full Text] [Related]

  • 4. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
    Jain VK, Judde JG, Max EE, Magrath IT.
    J Immunol; 1993 Jun 15; 150(12):5418-28. PubMed ID: 8515068
    [Abstract] [Full Text] [Related]

  • 5. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE, Lieberman R, Sandlund J, Kiwanuka J, Novikovs L, Kirsch I, Hollis G, Magrath IT.
    Cancer Res; 1989 Jun 15; 49(12):3235-41. PubMed ID: 2497974
    [Abstract] [Full Text] [Related]

  • 6. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT, Neckers LM, Schneller HE, Woodruff LS, Magrath IT.
    Cancer Res; 1993 Jan 01; 53(1):127-32. PubMed ID: 8416737
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B.
    EMBO J; 1996 Jan 15; 15(2):375-82. PubMed ID: 8617212
    [Abstract] [Full Text] [Related]

  • 8. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K, Mautner J, Strobl LJ, Wolf DA, Christoph B, Geltinger C, Polack A.
    Oncogene; 1995 Apr 06; 10(7):1393-401. PubMed ID: 7731690
    [Abstract] [Full Text] [Related]

  • 9. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K, Borkhardt A, Wössmann W, Reiter A, Harbott J.
    Haematologica; 2004 Jul 06; 89(7):818-25. PubMed ID: 15257933
    [Abstract] [Full Text] [Related]

  • 10. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M, Neuberger MS.
    Oncogene; 2000 Jul 13; 19(30):3404-10. PubMed ID: 10918597
    [Abstract] [Full Text] [Related]

  • 11. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR, Janz S, Potter M.
    Cancer Res; 1995 Nov 01; 55(21):5012-8. PubMed ID: 7585544
    [Abstract] [Full Text] [Related]

  • 12. Burkitt's lymphoma cell lines producing truncated mu immunoglobulin heavy chains lacking part of the variable region.
    Cogné M, Mounir S, Preud'homme JL, Nau F, Guglielmi P.
    Eur J Immunol; 1988 Oct 01; 18(10):1485-9. PubMed ID: 2847931
    [Abstract] [Full Text] [Related]

  • 13. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
    Busch K, Keller T, Fuchs U, Yeh RF, Harbott J, Klose I, Wiemels J, Novosel A, Reiter A, Borkhardt A.
    Leukemia; 2007 Aug 01; 21(8):1739-51. PubMed ID: 17541401
    [Abstract] [Full Text] [Related]

  • 14. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
    Wilda M, Busch K, Klose I, Keller T, Woessmann W, Kreuder J, Harbott J, Borkhardt A.
    Genes Chromosomes Cancer; 2004 Oct 01; 41(2):178-82. PubMed ID: 15287031
    [Abstract] [Full Text] [Related]

  • 15. Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives.
    Eick D, Piechaczyk M, Henglein B, Blanchard JM, Traub B, Kofler E, Wiest S, Lenoir GM, Bornkamm GW.
    EMBO J; 1985 Dec 30; 4(13B):3717-25. PubMed ID: 3004968
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
    Cutrona G, Carpaneto EM, Ponzanelli A, Ulivi M, Millo E, Scarfì S, Roncella S, Benatti U, Boffa LC, Ferrarini M.
    Cancer Res; 2003 Oct 01; 63(19):6144-8. PubMed ID: 14559793
    [Abstract] [Full Text] [Related]

  • 17. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.
    Oncogene; 1996 Jul 04; 13(1):105-15. PubMed ID: 8700536
    [Abstract] [Full Text] [Related]

  • 18. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A, Mautner J, Geltinger C, Hörtnagel K, Christoph B, Asenbauer H, Klobeck G, Polack A, Bornkamm GW.
    Oncogene; 1999 Mar 04; 18(9):1745-53. PubMed ID: 10208435
    [Abstract] [Full Text] [Related]

  • 19. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations.
    Rätsch A, Joos S, Kioschis P, Lichter P.
    Exp Cell Res; 2002 Feb 01; 273(1):12-20. PubMed ID: 11795942
    [Abstract] [Full Text] [Related]

  • 20. Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc.
    Joos S, Haluska FG, Falk MH, Henglein B, Hameister H, Croce CM, Bornkamm GW.
    Cancer Res; 1992 Dec 01; 52(23):6547-52. PubMed ID: 1330296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.